Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study

This publication has 25 references indexed in Scilit:

• CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals
  Nature Medicine, 2008
• CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms
  Nature Immunology, 2007
• Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy
  Immunity, 2007
• Virological Control during the First 6–18 Months after Initiating Highly Active Antiretroviral Therapy as a Predictor for Outcome in HIV-Infected Patients: A Danish, Population-Based, 6-Year Follow-Up Study
  Clinical Infectious Diseases, 2006
• HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication
  Clinical Infectious Diseases, 2005
• HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
  Proceedings of the National Academy of Sciences, 2000
• HIV-infected long-term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications
  Microbes and Infection, 1999
• Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters
  The Journal of Infectious Diseases, 1999
• Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study
  JAMA, 1996
• Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1995